On the other hand, it has recently been argued that rather than being causal of metabolic dysfunction, elevated Lcn2 may instead provide a protective mechanism to mitigate obesity-induced dysregulation and preserve pancreatic β-cell function [210]. The gene discussed is LCN2; the disease is obesity due to melanocortin 4 receptor deficiency.